Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Berlin - Delayed Quote • EUR Fresenius SE & Co KGaA (FRE.BE) Follow Add holdings 39.95 +0.14 +(0.35%) At close: April 25 at 9:52:04 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for FRE.BE 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: FRE.BE View More All News Press Releases SEC Filings Investors more bullish on Fresenius SE KGaA (ETR:FRE) this week as stock ascends 5.8%, despite earnings trending downwards over past year Is Concentra Group Holdings Parent, Inc. (CON) Outperforming Other Medical Stocks This Year? Here's Why Fresenius (FMS) is a Strong Momentum Stock Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock? The Zacks Analyst Blog Highlights Pacira Biosciences, Edgewise, Sarepta Therapeutics, Amgen and Bristol Myers Squibb Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More PCRX Stock Soars on Exparel Patent Settlement With Generic Players Update: Pacira Biosciences Settles Patent Litigations Over Local Analgesic; Shares Rise Pre-bell Pacira Biosciences Settles Patent Litigations Over Local Analgesic Why Is Nevro (NVRO) Up 0.9% Since Last Earnings Report? Why Fresenius (FMS) is a Top Value Stock for the Long-Term